Lung Cancer

Top Story

Opioid deaths significantly less common among individuals with cancer

Opioid deaths significantly less common among individuals with cancer
September 24, 2018
FDA News

FDA lifts partial clinical hold on tazemetostat trials

September 24, 2018
The FDA lifted a partial clinical hold it had placed on clinical trials designed to evaluate tazemetostat, according to the drug’s manufacturer. Tazemetostat…

Lung cancer specialist joins Perlmutter Cancer Center

September 23, 2018
Vamsidhar “Vamsi” Velcheti, MD, joined NYU Langone Health’s Perlmutter Cancer Center as director of thoracic medical oncology. Velcheti’s…

UCLA researchers receive grant to study combination therapy for lung cancer

September 18, 2018
Researchers at UCLA received $12 million to conduct a study of pembrolizumab in combination with patients’ genetically modified immune cells for treatment of…
More Headlines »

Ace the Case: A 70-Year-Old Woman with Cough and a Lung Mass

There is no commercial support for this activity.

This “Ace the Case” activity will discuss the diagnosis and management of a 70-year-old woman with cough…
More »

Baseball star who survived melanoma ‘suffering’ from lack of sunscreen use

September 22, 2017
More »
Resource Centers
Immuno-Oncology Resource Center

Immuno-Oncology Resource Center


Applying Advances with Checkpoint Inhibitors in Thoracic Oncology

This activity is supported by an educational grant from Merck & Co., Inc.

Lung cancer is a leading cause of cancer-related deaths worldwide. It is estimated that 222,500 new cases of lung…
More »